Page 18 of 157

Free image courtesy of FreeDigitalPhotos.net

The debate continues over Prostate Cancer Screening tests and the new opinion is that screening with the PSA ( prostate specific antigen) may prevent 17,000 advanced cases yearly.

The problem with screening is how to proceed going forward if cancer is detected.

Watchful waiting or invasive treatments which may cause serious side effects are often the choice.

Many times the cancer is slow growing and would never had been detected as there are often no symptoms.

Last year, an influential organization called the U.S. Services Preventive Task Force (USPSTF) recommended against prostate cancer screening altogether, saying its harms outweigh its benefits.

Recent studies on the topic have also had conflicting results, with some suggesting prostate cancer screening saves lives, and others finding no benefit.

The researchers say their new findings should be taken into consideration when creating PSA screening recommendations.

“There are trade-offs associated with the PSA test, and many factors influence the disease outcome,” said study researcher Dr. Edward Messing, chairman of urology at the University of Rochester Medical Center. “And yet our data are very clear: not doing the PSA test will result in many men presenting with far more advanced prostate cancer.”